ARCHIVES

Cancer Groups In Campaign To Draft Pazdur For FDA.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Mammography Hazard In ACS-NCI Screening Charged

October 17, 1975

NCI program announcement available, contract awards listed.

November 14, 2003

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable

April 29, 2011

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007